Dr. Robin Hsiung, MD
Claim this profileUBC Hospital
Studies Alzheimer's Disease
Studies Dementia
10 reported clinical trials
16 drugs studied
Area of expertise
1Alzheimer's Disease
APP positive
PSEN1 positive
PSEN2 positive
2Dementia
APP positive
PSEN1 positive
PSEN2 positive
Affiliated Hospitals
Clinical Trials Robin Hsiung, MD is currently running
Gantenerumab
for Alzheimer's Disease
The purpose is to evaluate the biomarker effect, safety, and tolerability of investigational study drugs in participants who are known to have an Alzheimer's disease (AD)-causing mutation. Stage 1 will determine if treatment with the study drug prevents or slows the rate of amyloid beta (Aβ) pathological disease accumulation demonstrated by Aβ positron emission tomography (PET) imaging. Stage 2 will evaluate the effect of early Aβ plaque reduction/prevention on disease progression by assessing downstream non-Aβ biomarkers of AD (e.g., CSF total tau, p-tau, NfL) compared to an external control group from the DIAN-OBS natural history study and the DIAN-TU-001 placebo-treated participants.
Recruiting0 awards Phase 2 & 310 criteria
Remternetug
for Alzheimer's Disease
The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomatic (at risk) Alzheimer disease in individuals with AD-causing mutations. This study will also investigate the effects of remternetug on biomarkers (measures of the disease including brain scans, blood and spinal fluid tests), examine safety data to identify any potential benefits or risks, and examine how well participants can tolerate remternetug. Stage 1 will determine if treatment with the study drug prevents or reverses amyloid beta (Aβ) accumulation compared with placebo in participants with dominantly inherited Alzheimer's disease (DIAD). Stage 2 will evaluate the effect of early anti-amyloid treatment on downstream biomarkers of AD in treated participants compared to external control groups.
Recruiting0 awards Phase 2 & 32 criteria
More about Robin Hsiung, MD
Clinical Trial Related7 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Robin Hsiung, MD has experience with
- Lecanemab
- Gantenerumab
- E2814
- Solanezumab
- Matching Placebo (Gantenerumab)
- Matching Placebo (E2814)
Breakdown of trials Robin Hsiung, MD has run
Alzheimer's Disease
Dementia
Frontotemporal Dementia
Pick's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robin Hsiung, MD specialize in?
Robin Hsiung, MD focuses on Alzheimer's Disease and Dementia. In particular, much of their work with Alzheimer's Disease has involved APP positive patients, or patients who are PSEN1 positive.
Is Robin Hsiung, MD currently recruiting for clinical trials?
Yes, Robin Hsiung, MD is currently recruiting for 3 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Robin Hsiung, MD has studied deeply?
Yes, Robin Hsiung, MD has studied treatments such as Lecanemab, Gantenerumab, E2814.
What is the best way to schedule an appointment with Robin Hsiung, MD?
Apply for one of the trials that Robin Hsiung, MD is conducting.
What is the office address of Robin Hsiung, MD?
The office of Robin Hsiung, MD is located at: UBC Hospital, Vancouver, British Columbia V6T 2B5 Canada. This is the address for their practice at the UBC Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.